Diet Modification — Impact of School Based Education Program
Citation(s)
Ali HI, Ng SW, Zaghloul S, Harrison GG, Qazaq HS, El Sadig M, Yeatts K High proportion of 6 to 18-year-old children and adolescents in the United Arab Emirates are not meeting dietary recommendations. Nutr Res. 2013 Jun;33(6):447-56. doi: 10.1016/j.nutres.2013.03.008. Epub 2013 May 4.
Collins CE, Dewar DL, Schumacher TL, Finn T, Morgan PJ, Lubans DR 12 month changes in dietary intake of adolescent girls attending schools in low-income communities following the NEAT Girls cluster randomized controlled trial. Appetite. 2014 Feb;73:147-55. doi: 10.1016/j.appet.2013.11.003. Epub 2013 Nov 12.
Fahlman MM, Dake JA, McCaughtry N, Martin J A pilot study to examine the effects of a nutrition intervention on nutrition knowledge, behaviors, and efficacy expectations in middle school children. J Sch Health. 2008 Apr;78(4):216-22. doi: 10.1111/j.1746-1561.2008.00289.x.
Hassan-Wassef H Food habits of the Egyptians: newly emerging trends. East Mediterr Health J. 2004 Nov;10(6):898-915.
Murimi MW, Kanyi M, Mupfudze T, Amin MR, Mbogori T, Aldubayan K Factors Influencing Efficacy of Nutrition Education Interventions: A Systematic Review. J Nutr Educ Behav. 2017 Feb;49(2):142-165.e1. doi: 10.1016/j.jneb.2016.09.003. Epub 2016 Nov 1. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
